Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05478304 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Study acronym: LeAAPS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 143 to 138v25
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 6500 to confirmed 6573
    • Site details revised at 143 of 143 sites
    v24
  3. Study sites: 135 to 143v23
  4. Study sites: 127 to 135v22
  5. Study sites: 121 to 127v21
Show 19 earlier versionsHide 19 earlier versions
  1. Study sites: 115 to 121v20
  2. Study sites: 110 to 115v19
  3. Study sites: 102 to 110v18
  4. Study sites: 97 to 102v17
  5. Study sites: 93 to 97v16
  6. Study sites: 81 to 93v15
  7. Study sites: 77 to 81v14
  8. Study sites: 68 to 77v13
  9. Study sites: 65 to 68v12
  10. Study sites: 62 to 65v11
  11. Study sites: 53 to 62v10
  12. Study sites: 48 to 53v9
  13. Study sites: 42 to 48v8
  14. Study sites: 31 to 42v7
  15. Study sites: 26 to 31v6
  16. Study sites: 19 to 26v5
  17. Study sites: 16 to 19v4
  18. Study sites: 5 to 16v3
  19. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 5
    • Start date changed from estimate of Oct 2022 to Jan 25, 2023
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AtriCure, Inc.
9 trials monitored
See 1 trial at risk
Stroke
3,531 trials monitored
See 153 trials at risk
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
Trial Details
NCT Number NCT05478304
Lead Sponsor AtriCure, Inc.
Collaborators: Population Health Research Institute
Conditions
(from sponsor)		 Ischemic Stroke, Systemic Embolism
Related terms Ischemic Stroke
Enrollment 6,573 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov